You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 1, January 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Surgery, Other
 •Alert me on articles by topic

Prophylaxis With Oral Granisetron for the Prevention of Nausea and Vomiting After Laparoscopic Cholecystectomy

A Prospective Randomized Study

Yoshitaka Fujii, MD; Hiroyoshi Tanaka, MD; Tsuneo Kawasaki, MD

Arch Surg. 2001;136:101-104.

Hypothesis  Laparoscopic cholecystectomy is associated with a relatively high incidence of postoperative nausea and vomiting when no prophylactic antiemetic is given. This study assesses the efficacy and safety of oral granisetron hydrochloride for the prevention of nausea and vomiting after laparoscopic cholecystectomy.

Design  A prospective, randomized, double-blind, placebo-controlled study.

Setting  University teaching hospital.

Patients  The study comprised 120 patients, 92 women and 28 men, undergoing laparoscopic cholecystectomy.

Interventions  Patients received orally either placebo or granisetron at 3 different doses (1 mg, 2 mg, and 4 mg; n = 30 of each) 60 minutes before surgery. A standard general anesthetic technique and postoperative analgesia were used.

Main Outcome Measures  Emetic episodes were recorded during the first 24 hours after anesthesia.

Results  The incidence of patients who were emesis-free 24 hours after anesthesia was 60% with 1 mg of granisetron (P = .40), 83% with 2 mg of granisetron (P = .01), and 83% with 4 mg of granisetron (P = .01), compared with placebo (53%). No clinically important adverse effects were observed in any of the groups.

Conclusion  Preoperative oral granisetron in doses higher than 2 mg is effective for the prevention of nausea and vomiting after laparoscopic cholecystectomy.


From the Departments of Anesthesiology (Drs Fujii and Tanaka) and Surgery (Dr Kawasaki), Toride Kyodo General Hospital, Toride City, Ibaraki, Japan.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery.
White et al.
Anesth. Analg. 2006;102:1387-1393.
ABSTRACT | FULL TEXT  

Evidence-Based Practice in Laparoscopic Surgery: Perioperative Care
Goldfaden and Birkmeyer
SURG INNOV 2005;12:51-61.
ABSTRACT  

Granisetron: An Update on its Clinical Use in the Management of Nausea and Vomiting
Aapro
The Oncologist 2004;9:673-686.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.